Home / Market News / $DCOY

$DCOY news and market catalysts

The 2 most recent market catalysts affecting $DCOY, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

2 catalysts 0 high impact 2 bullish 0 bearish Biotechnology
Sep 29, 2026 Corporate Catalyst Bullish Impact 65
Decoy Therapeutics Says Preclinical Data Show Single Intranasal Dose Of DCOY-CoV Maintains Drug Levels For Up To 7 Days; Expects Clinical Trials In 2027
This headline is a positive corporate catalyst for Decoy Therapeutics. The preclinical data indicating sustained drug levels for up to 7 days with a single intranasal dose is a sig…
Sep 22, 2026 Corporate Catalyst Bullish Impact 55
Decoy Therapeutics Announces Its Exploring Non-Dilutive Federal Grants, Public Health Collaborations To Support Preclinical, Clinical Development Of Biodefense Pipeline
Decoy Therapeutics is shifting its corporate strategy to focus on biodefense, specifically a pan-filovirus program, and is seeking non-dilutive federal grants and public health col…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.